Chronic exposure of IL-17 would lead to a pro-tumor microenvironment via production of inflammatory mediators, mobilizing myeloid cells and a phenotypic switch of stromal cells (Zhao et al., 2020). This evidence concerns the gene IL17A and neoplasm.